Created On: 2020-07-15
Record Count: 6
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 29294
IPSCIO Record ID: 29425
Paxil CRâ„¢ is a modified release version of Paxil/Seroxat (paroxetine HCL) which uses a combination of the Positioned Release and Zero Order Geomatrixâ„¢ systems. Paxil is an FDA-approved drug that is currently marketed primarily in the United States and Europe and is an immediate release formulation prescribed for central nervous system disorders.
IPSCIO Record ID: 26466
IPSCIO Record ID: 7340
IPSCIO Record ID: 7324
In return, the Licensee granted the Company an exclusive license to use Licensee's technology for certain applications.
The TUNA System is designed to offer a minimally invasive alternative for the treatment of benign prostatic hyperplasia by selectively shrinking the hyperplastic tissue that compresses the urethra limiting urinary flow.
IPSCIO Record ID: 27477
Paxil CR is a modified release version of Paxil/Seroxat (paroxetine) using a combination of the Positioned Release and Zero Order Geomatrix systems. Paxil is an FDA-approved (February 1999) drug that is currently marketed primarily in the United States and Europe. In early 2001 an approvable letter from the FDA was received for a second CR indication, panic disorder. A third CR indication, pre-menstrual dysphoric disorder, a severe form of pre-menstrual syndrome is being developed. In April, 2002, the product was launched in the U.S. Note that in May 2005, they renegotiated this license and the upper range of the royalty payment was increased.